Page 4 - Pacbio Sequel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Shoreline Biome Granted Foundational Patent for High Resolution Microbiome Analysis Technology Share Article FARMINGTON, Conn. (PRWEB) January 26, 2021 Shoreline Biome, a microbiome research company that develops tools for characterizing microbiome populations down to the strain level, was recently awarded a new patent by the United States Patent and Trademark Office. The patent, U.S. Patent 10,894,990, was awarded January 19, 2021, for a "High Throughput Method For Identification and Sequencing of Unknown Microbial and Eukaryoti...

genetic variants that influence the amount or function of human “helper proteins” that support or facilitate SARS-CoV-2. The gene variants reveal potential target structures for new drugs. The researchers have now published their results in Nature Communications. The team examined 179 proteins known to be involved in SARS-CoV-2 infection for their naturally occurring variants. They discovered 38 targets for existing drugs as well as evidence that certain proteins that interact with the virus influence the immune system. DOI: 10.1038/s41467-020-19996-z In all-cause excess mortality and ...

Leading UK Core Labs Expand Investment in PacBio Sequencing Systems to Power Life Science Research with HiFi Reads Edinburgh Genomics, Oxford Genomics Centre, and University of Liverpool Centre for Genomic Research have added new PacBio Sequel II & IIe Systems to their service laboratories Pacific Biosciences of California, Inc. Menlo Park, California, UNITED STATES MENLO PARK, Calif., Dec. 14, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenome...